Fall is here and so are new ways to accelerate your research and connect with the scientific community! Whether you are joining us at Neuroscience 2025, exploring our latest datasets, or ordering from our expanding collections, there’s a lot to get excited about.
Calling all data enthusiasts! The new Developers Portal provides approved users with structured, high-quality plasmid and sequence data. Access bulk datasets in JSON format or connect through API endpoints to integrate Addgene data directly into your workflows, tools, and analyses.
This portal makes it easier for researchers and developers to work with Addgene’s plasmid data quickly and efficiently, supporting faster, more informed scientific discovery.
We’re celebrating Addgene’s President and Executive Director, Dr. Chonnettia Jones, for two exciting recognitions!
Top Women in Biopharma R&D Chonnettia was named one of Endpoints News’ 2025 Top Women in Biopharma R&D for her leadership in advancing global scientific sharing. Read the full feature →
NIH Data Sharing Index (S-Index) Challenge Finalist She also collaborated with a multidisciplinary team to develop a new framework for measuring data sharing impact. Their approach — which emphasizes collaboration, reproducibility, and long-term sustainability — was selected as a finalist in the competition. Learn more →
We’re proud to see Addgene’s leadership recognized for driving open, reproducible, and impactful science.
Product Updates
Expanded Viral Vector Packaging Services
Get your AAVs packaged quickly and reliably — choose from ready-to-ship preps or customize your vector with our Packaged on Request service. With robust QC, multiple serotypes, and flexible volumes, we make it easy to focus on your research while we handle the rest.
Our partnership with Promega continues to grow! Hundreds of new luciferase reporters and tagged ORF constructs are now available to all researchers – industry and academic – with no MTA required. Explore tools that make your signaling and protein interaction studies shine.
